Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SCIENION and Innopsys Agree on a Joint Product Offering for RPPA

Published: Tuesday, March 26, 2013
Last Updated: Monday, March 25, 2013
Bookmark and Share
Added value for customers combining technologies of both companies into a complete assay solution.

SCIENION AG and Innopsys have announced a cooperation agreement on a seamless integration of its microarray production and detection equipment.

Combining technologies of both companies will benefit our customers for a broad range of applications. A good example is “reverse phase protein array” (RPPA).

RPPA is a high-throughput antibody-based technique developed for functional proteomics studies to evaluate protein activities in biological networks.

This is useful in identifying drug selectivity, classifying tumors, predicting responses to target therapies, and many more. Lysates from cultured cells or patient tissue samples are typically deposited and incubated on nitrocellulose membranes.

Scienion’s sciFLEXARRAYER technology can precisely and gently print lysates on nitrocellulose coated glass slides without damage to the surface.

Innopsys InnoScan® 710-IR near infrared scanner is the only product that allows for an IR detection readout of these arrays. It combines a 3µm per pixel resolution with 670 nm and 785 nm excitation lasers, a spectral range where the auto-fluorescence of nitrocellulose that is typically present in the visible range is significantly decreased.

This product combination will significantly improve signal to noise ratios. Systems will be offered as full out-of-the-box solutions, where equipment and software have been configured to execute RPPA assays from A to Z. This will lower the barrier of entry, allowing more researchers to experiment with RPPA.

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “We are very pleased to offer a complete solution that integrates Innopsys’ high resolution scanners, especially its unique IR detection devices. The InnoScan® products complement our own colorimetric scanner sciREADER CL. Our customers will benefit from combining state-of-the-art printing and detection technologies of both companies, including full configuration and software integration, enabling advance performance and automation for such multiplex assays.”

Dr. Laurence BOUET, Executive and Sales Director of INNOPSYS, comments: “SCIENION and Innopsys focus on top quality and high performance products and we target the same clientele. I view our initial collaboration as an ideal match of partners. We appreciate this new cooperation as a promising opportunity to scale up outreach and we look forward to identify further areas for joint activities.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
Scientific News
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
‘NoBody,’ a Microprotein On a Mission
Researchers identify over 400 microproteins encoded in the human genome, one of which clears unneeded genetic material inside cells.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Largest Resource of Protein-Protein Interactions
Researchers have developed the largest ever database of protein-protein interactions.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Building Better Nanodiscs
Researchers have improved upon the design of nanodiscs that provide an unprecedented view of viral infection.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!